On the Board | GenomeWeb

On the Board

Some 40 percent of the largest pharmaceutical companies have at least one board member on their board of directors who is also in a leadership position at an academic medical center, researchers led by Walid Gellad from the VA Pittsburgh Healthcare System and his colleagues report in the Journal of the American Medical Association this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.